Stomach Cancer Causes
Stomach Cancer Causes
Most stomach cancer arises in a stomach that has been inflamed for years — usually by Helicobacter pylori, often helped by diet and smoking. A minority is inherited. Most of the modifiable risk sits before the cancer, not after it.
Age and sex
Stomach cancer is a disease of middle and later life, with most cases occurring after 50, and it is roughly twice as common in men as in women. Neither of these is modifiable, but both belong in the risk calculation: a man over 50 with upper abdominal symptoms and a risk factor has a lower threshold for endoscopy than a 28-year-old with the same complaint.
Helicobacter pylori: the single strongest factor
Helicobacter pylori is a bacterium that colonises the stomach lining, usually acquired in childhood and persisting for life unless treated. It is classified by the International Agency for Research on Cancer as a Group 1 carcinogen — a cause of cancer in humans — and chronic infection is the dominant risk factor for non-cardia gastric cancer worldwide.
The relationship needs stating carefully, because it is often misread. Most people infected with H. pylori never develop stomach cancer — the outcome depends on the bacterial strain, the host's inflammatory response, diet, and decades of exposure. But the direction of the association is not in doubt, and it is the reason eradicating the infection is a cancer-prevention measure and not merely a treatment for indigestion.
Testing is simple — a breath test, a stool antigen test, or a biopsy taken during endoscopy — and eradication is a short course of medication. If you are infected and have a family history or a stomach lining that has already changed, this is the single most useful thing to act on.
Diet: salt, preservation and what is missing
The dietary pattern associated with stomach cancer is consistent across studies: high salt intake, heavily salted and pickled foods, smoked and cured meats, and processed meat, together with low intake of fresh fruit and vegetables. Salt damages the stomach lining and makes it more vulnerable to carcinogens; preserved foods carry nitrites and other compounds formed during preservation; and fruit and vegetables appear protective.
The geographic pattern follows this. Stomach cancer is common in East Asia and parts of South America where preserved and salted foods have been dietary staples, and it has fallen in countries where refrigeration replaced salting and smoking as the way to keep food. That fall is one of the clearest cancer-prevention stories we have, and it happened without a single new drug.
Family history and inherited syndromes
Most gastric cancer is not inherited, but a minority is, and the syndromes matter because they change surveillance from optional to mandatory:
- Hereditary diffuse gastric cancer (CDH1 mutations) — diffuse-type cancer, often at a young age; families carrying a CDH1 mutation receive specific, aggressive management recommendations.
- Lynch syndrome — the mismatch-repair gene syndromes, better known for colorectal cancer, which also raise gastric cancer risk and already carry a colonoscopy surveillance programme.
- Familial adenomatous polyposis — gastric polyps are part of the syndrome and are followed endoscopically.
- Family history without an identified mutation — one first-degree relative raises risk; more than one, or a diagnosis before 50, raises the threshold for surveillance considerably.
Where a syndrome is suspected, genetic counselling and testing on a blood sample is the route; testing only the best-known genes can miss a family's actual mutation, which is why panel testing is used where testing is indicated.
The precursors: changes that come before cancer
Gastric cancer usually develops along a sequence that takes years: normal lining → chronic inflammation (H. pylori gastritis) → atrophic gastritis (glands lost) → intestinal metaplasia (the lining takes on intestine-like features) → dysplasia → cancer. Each step is visible at endoscopy with biopsy, and each step is a point where surveillance rather than treatment is the response.
This sequence explains several things that otherwise look arbitrary. Why a biopsy is taken even from an endoscopically normal-looking stomach in a high-risk patient. Why a report saying "atrophic gastritis with intestinal metaplasia" is not a diagnosis of cancer but also not a dismissal. And why the extent and stage of metaplasia determine the surveillance interval rather than the presence or absence of symptoms — symptoms in this sequence are late.
A previous partial gastrectomy for a benign condition, performed decades earlier, is also associated with later cancer in the remnant — a reason patients with that history remain under endoscopic follow-up long after the original operation.
Other factors
- Smoking — a consistent, dose-related risk factor, particularly for cancer near the cardia.
- Obesity and reflux — relevant mainly for cancers of the gastro-oesophageal junction, which share risk factors with oesophageal adenocarcinoma.
- Epstein–Barr virus — a small subset of gastric cancers carries EBV in the tumour cells and has a distinct molecular profile.
- Blood group A — a statistical association reported in older studies; a curiosity rather than something to act on.
- Pernicious anaemia — autoimmune destruction of the acid-producing mucosa produces a stomach lining prone to the same precursor sequence.
Three things that do not cause it
Spicy food — capsaicin has not been shown to cause gastric cancer, and the association often reported is really with the salt and preserved components of the same cuisines. Stress — it worsens functional symptoms and can mimic them, but it is not a cause of cancer. Eating irregularly or skipping meals — a common explanation patients are given, with no evidence behind it. None of these should displace the factors that are real: H. pylori, diet pattern, smoking and family history.
What to do with this
Of the factors above, three are actionable and one is surveillance. Eradicate H. pylori if you carry it. Change the salt-and-preservation pattern and stop smoking. And if you have a family history, a precursor finding on a previous biopsy, or a syndrome, arrange endoscopic surveillance at an interval that matches that risk rather than waiting for a symptom. The prevention page sets out how the intervals are decided.